Joalland, N., Quéméner, A., Deshayes, S., Humeau, R., Maillasson, M., Lebihan, H., . . . ANR-11-LABX-0016,IGO,Immunothérapies Grand Ouest(2011). (2025). New soluble CSF-1R-dimeric mutein with enhanced trapping of both CSF-1 and IL-34 reduces suppressive tumor-associated macrophages in pleural mesothelioma. ISSN: 2051-1426 ; Journal for Immunotherapy of Cancer ; https://inserm.hal.science/inserm-05036353 ; Journal for Immunotherapy of Cancer, 2025, 13 (3), pp.e010112. ⟨10.1136/jitc-2024-010112⟩. https://doi.org/10.1136/jitc-2024-010112
Παραπομπή σε μορφή Chicago (17η εκδ.)Joalland, Noémie, et al. "New Soluble CSF-1R-dimeric Mutein with Enhanced Trapping of Both CSF-1 and IL-34 Reduces Suppressive Tumor-associated Macrophages in Pleural Mesothelioma." ISSN: 2051-1426 ; Journal for Immunotherapy of Cancer ; Https://inserm.hal.science/inserm-05036353 ; Journal for Immunotherapy of Cancer, 2025, 13 (3), Pp.e010112. ⟨10.1136/jitc-2024-010112⟩ 2025. https://doi.org/10.1136/jitc-2024-010112.
Παραπομπή σε μορφή MLA (9th εκδ.)Joalland, Noémie, et al. "New Soluble CSF-1R-dimeric Mutein with Enhanced Trapping of Both CSF-1 and IL-34 Reduces Suppressive Tumor-associated Macrophages in Pleural Mesothelioma." ISSN: 2051-1426 ; Journal for Immunotherapy of Cancer ; Https://inserm.hal.science/inserm-05036353 ; Journal for Immunotherapy of Cancer, 2025, 13 (3), Pp.e010112. ⟨10.1136/jitc-2024-010112⟩, 2025, https://doi.org/10.1136/jitc-2024-010112.